Solomon Nwaka 2

Dr.  Solomon Nwaka

Retired: Director of Drug Discovery at the Medicines for Malaria Venture

 

Dr. Solomon Nwaka’s scientific and management career spans different public and international organizations, biopharmaceutical industry and public-private partnership in several countries including the USA, Canada, Germany, Japan, Belgium, Italy, Switzerland and Nigeria. Presently, he is the leader of drug discovery for infectious tropical diseases, and  innovation for product development in developing countries at the Special Programme for Research and training in Tropical Diseases,  World Health Organization, Geneva Switzerland.
Prior to joining WHO, he was the Director of Drug Discovery at the Medicines for Malaria Venture (MMV), a public-private partnership. He also worked as a Senior Scientist and member of the management team at a Canadian Biopharmaceutical company.
He has  published broadly on drug R&D, public-private partnerships, as well as innovative models to stimulate health product R&D and access in developing countries. He hold a PhD with emphasis in molecular biology and biochemistry, and remains interested in capacity development for product R&D in developing countries. He has received several fellowships/awards and serve in a number of Scientific Editorial and Advisory Boards

Other Members


April 4, 2018

Dr.  Solomon Nwaka

Dr. Solomon Nwaka's scientific and management career spans different public and international organizations, biopharmaceutical industry and public-private partnership
April 4, 2018

Genomic Characterization and Surveillance of Microbial Threats in West Africa

Overall Recent viral outbreaks in West Africa, specifically the 2013-16 Ebola Virus Outbreak, shed light on the many limitations of current surveillance and diagnostics in the region’s public health systems. Tools for rapid, accurate
April 4, 2018

Dr. Osman Sankoh

INDEPTH, Ghana
April 4, 2018

AWI-Gen 2: Genomic and environmental risk factors for cardiometabolic disease in Africans

The long-term vision of the Collaborative Centre (CC) is to build sustainable capacity in Africa for research that leads to an understanding of the interplay between genetic, epigenetic and environmental risk factors for obesity and related cardiometabolic diseases (CMD) in sub-Saharan Africa.
April 4, 2018

Dr. Michèle Ramsay

Dr. Michèle Ramsay Professor, Division of Human Genetics at the […]
April 4, 2018

Prof. Bruce Ovbiagele

Medical University of South Carolina Charleston, SC, USA
April 4, 2018

Prof. Mayowa Owolabi

University of Ibadan Ibadan, Nigeria
April 4, 2018

Prof. Oathokwa Nkomazana

University of Botswana Faculty of Biological Sciences Gaborone, Botswana
April 4, 2018

Prof. Sununguko Wata Mpoloka

University of Botswana Faculty of Biological Sciences Gaborone, Botswana